• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

桡动脉入路降低 ST 段抬高型心肌梗死围术期死亡率和出血率。来自 ORPKI 波兰国家注册中心数据的倾向评分分析。

Reduced periprocedural mortality and bleeding rates of radial approach in ST-segment elevation myocardial infarction. Propensity score analysis of data from the ORPKI Polish National Registry.

机构信息

Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.

出版信息

EuroIntervention. 2017 Sep 20;13(7):843-850. doi: 10.4244/EIJ-D-17-00078.

DOI:10.4244/EIJ-D-17-00078
PMID:28606891
Abstract

AIMS

We sought to evaluate bleeding complications and periprocedural outcomes of the radial approach (RA) as compared to the femoral approach (FA) during percutaneous coronary intervention (PCI) in "real-world" patients with ST-segment elevation myocardial infarction (STEMI).

METHODS AND RESULTS

The study group consisted of 22,812 consecutive patients with STEMI treated with PCI and stent implantation between January 2014 and June 2015 in 151 tertiary invasive cardiology centres in Poland (the ORPKI Polish National Registry). Patients treated using the RA and FA were compared using a propensity score analysis to avoid possible selection bias. The analysis was carried out in an "as-treated" manner. The FA was used in 9,334 (40.9%) and the RA in 13,478 (59.1%) patients. After propensity score matching, a higher total amount of contrast (191.8±8.0 vs. 174.8±68.8 ml; p=0.001) and lower radiation doses (1,279.5±1,346.3 vs. 1,182.6±887 mGy; p=0.02) were reported in FA. More access-site-related bleeding complications after both angiography (0.17% vs. 0.02%; p=0.004) and PCI (0.23% vs. 0.09%; p=0.049) were reported in the FA group. Periprocedural death (1.94% vs. 0.93%; p=0.001) was more common after PCI performed with the FA.

CONCLUSIONS

The radial approach was associated with a lower incidence of periprocedural death in STEMI patients as well as a significant reduction of bleeding complications at the access site.

摘要

目的

我们旨在评估在经皮冠状动脉介入治疗(PCI)中,与股动脉入路(FA)相比,桡动脉入路(RA)在 ST 段抬高型心肌梗死(STEMI)患者中的出血并发症和围手术期结局。

方法和结果

研究组纳入了 2014 年 1 月至 2015 年 6 月期间,波兰 151 个三级介入心脏病学中心(ORPKI 波兰国家注册中心)中 22812 例接受 PCI 和支架植入治疗的 STEMI 连续患者。使用倾向评分分析比较使用 RA 和 FA 治疗的患者,以避免可能的选择偏倚。分析采用“实际治疗”方式进行。FA 组 9334 例(40.9%),RA 组 13478 例(59.1%)。经过倾向评分匹配后,FA 组的造影剂总量(191.8±8.0 vs. 174.8±68.8 ml;p=0.001)和辐射剂量(1279.5±1346.3 vs. 1182.6±887 mGy;p=0.02)均较高。FA 组在造影(0.17% vs. 0.02%;p=0.004)和 PCI(0.23% vs. 0.09%;p=0.049)后,更多的血管入路相关出血并发症。FA 组行 PCI 后围手术期死亡率(1.94% vs. 0.93%;p=0.001)更高。

结论

与 FA 相比,RA 与 STEMI 患者围手术期死亡率较低以及血管入路部位出血并发症发生率显著降低相关。

相似文献

1
Reduced periprocedural mortality and bleeding rates of radial approach in ST-segment elevation myocardial infarction. Propensity score analysis of data from the ORPKI Polish National Registry.桡动脉入路降低 ST 段抬高型心肌梗死围术期死亡率和出血率。来自 ORPKI 波兰国家注册中心数据的倾向评分分析。
EuroIntervention. 2017 Sep 20;13(7):843-850. doi: 10.4244/EIJ-D-17-00078.
2
Impact of Access Site Practice on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention Following Thrombolysis for ST-Segment Elevation Myocardial Infarction in the United Kingdom: An Insight From the British Cardiovascular Intervention Society Dataset.英国经溶栓治疗的 ST 段抬高型心肌梗死患者行经皮冠状动脉介入治疗中穿刺部位操作对临床结局的影响:来自英国心血管介入学会数据集的见解。
JACC Cardiovasc Interv. 2017 Nov 27;10(22):2258-2265. doi: 10.1016/j.jcin.2017.07.049.
3
Radial approach reduces mortality in patients with ST-segment elevation myocardial infarction and cardiogenic shock.桡动脉入路可降低 ST 段抬高型心肌梗死合并心原性休克患者的死亡率。
Pol Arch Intern Med. 2021 May 25;131(5):421-428. doi: 10.20452/pamw.15886. Epub 2021 Mar 19.
4
Radial versus femoral access for percutaneous coronary intervention in ST-elevation myocardial infarction patients treated with fibrinolysis: Results from the randomized routine early invasive clinical trials.在接受溶栓治疗的ST段抬高型心肌梗死患者中,经皮冠状动脉介入治疗采用桡动脉入路与股动脉入路的比较:随机常规早期有创临床试验的结果
Cardiovasc Revasc Med. 2016 Jul-Aug;17(5):295-301. doi: 10.1016/j.carrev.2016.03.008. Epub 2016 Mar 28.
5
Impact of On-Site Surgical Backup on Periprocedural Outcomes of Primary Percutaneous Interventions in Patients Presenting With ST-Segment Elevation Myocardial Infarction (From the ORPKI Polish National Registry).现场手术备份对 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗的围术期结局的影响(来自 ORPKI 波兰国家注册研究)。
Am J Cardiol. 2018 Sep 15;122(6):929-935. doi: 10.1016/j.amjcard.2018.05.047. Epub 2018 Jun 26.
6
Radial or femoral access in primary percutaneous coronary intervention (PCI): Does the choice matters?经桡动脉或股动脉入路行直接经皮冠状动脉介入治疗(PCI):选择重要吗?
Indian Heart J. 2020 May-Jun;72(3):166-171. doi: 10.1016/j.ihj.2020.05.004. Epub 2020 May 21.
7
Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?经皮冠状动脉介入治疗中动脉入路选择对结果的影响:随机临床试验的结果能否在临床实践中实现?
JACC Cardiovasc Interv. 2013 Jul;6(7):698-706. doi: 10.1016/j.jcin.2013.03.011. Epub 2013 Jun 14.
8
Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study.药物介入与直接经皮冠状动脉介入策略治疗 ST 段抬高型心肌梗死患者的动脉入路与结局的关系:来自心肌梗死后早期强化再灌注策略(STREAM)研究的见解。
J Am Heart Assoc. 2016 Jun 13;5(6):e003559. doi: 10.1161/JAHA.116.003559.
9
Transition Towards Transradial Approach Improves Outcomes of Acute Myocardial Infarction PCI.向桡动脉途径的转变改善了急性心肌梗死PCI的预后。
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2017 Sep 1;38(2):69-78. doi: 10.1515/prilozi-2017-0024.
10
ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trial.多中心随机临床试验中经桡动脉或股动脉途径治疗 ST 段抬高型心肌梗死:STEMI-RADIAL 试验。
J Am Coll Cardiol. 2014 Mar 18;63(10):964-72. doi: 10.1016/j.jacc.2013.08.1651. Epub 2013 Nov 21.

引用本文的文献

1
Clinical Characteristics and Outcomes of Elderly Patients Undergoing Primary Percutaneous Coronary Intervention: An Observational Cohort Study.接受直接经皮冠状动脉介入治疗的老年患者的临床特征与结局:一项观察性队列研究
Glob Heart. 2024 Dec 30;19(1):99. doi: 10.5334/gh.1383. eCollection 2024.
2
Sex Differences in Fractional Flow Reserve Utilization.血流储备分数应用中的性别差异
J Clin Med. 2024 Jul 10;13(14):4028. doi: 10.3390/jcm13144028.
3
Trends in primary percutaneous coronary intervention for the treatment of acute coronary ST-elevation myocardial infarction in Latin American countries: insights from the CECI consortium.
拉丁美洲国家急性冠状动脉ST段抬高型心肌梗死的主要经皮冠状动脉介入治疗趋势:CECI联盟的见解
Front Cardiovasc Med. 2024 May 17;11:1275907. doi: 10.3389/fcvm.2024.1275907. eCollection 2024.
4
Impact of COVID-19 Pandemic on Patients with ST-Segment-Elevation Myocardial Infarction Complicated by Out-of-Hospital Cardiac Arrest.COVID-19 大流行对合并院外心脏骤停的 ST 段抬高型心肌梗死患者的影响。
Int J Environ Res Public Health. 2022 Dec 26;20(1):337. doi: 10.3390/ijerph20010337.
5
Development of a Clinical Risk Score for Prediction of Life-Threatening Arrhythmia Events in Patients with ST Elevated Acute Coronary Syndrome after Primary Percutaneous Coronary Intervention.ST 段抬高型急性冠状动脉综合征患者经皮冠状动脉介入治疗后发生致命性心律失常事件的临床风险评分的制定。
Int J Environ Res Public Health. 2022 Feb 10;19(4):1997. doi: 10.3390/ijerph19041997.
6
Length of Stay and Short-Term Outcomes in Patients with ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention: Insights from the China Acute Myocardial Infarction Registry.直接经皮冠状动脉介入治疗后ST段抬高型心肌梗死患者的住院时间及短期预后:来自中国急性心肌梗死注册研究的见解
Int J Gen Med. 2021 Sep 22;14:5981-5991. doi: 10.2147/IJGM.S330379. eCollection 2021.
7
Treatment Delay and Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction during the COVID-19 Pandemic.COVID-19大流行期间ST段抬高型心肌梗死患者的治疗延迟与临床结局
J Clin Med. 2021 Aug 30;10(17):3920. doi: 10.3390/jcm10173920.
8
Concomitant multi-vessel disease is associated with a lower procedural death rate in patients treated with percutaneous coronary interventions within the left main coronary artery (from the ORPKI registry).在接受经皮冠状动脉介入治疗的左主干冠状动脉患者中(来自ORPKI注册研究),合并多支血管病变与较低的手术死亡率相关。
Arch Med Sci. 2019 Jun 22;17(4):881-890. doi: 10.5114/aoms.2019.82666. eCollection 2021.
9
Clinical and procedural characteristics of COVID-19 patients treated with percutaneous coronary interventions.经皮冠状动脉介入治疗的 COVID-19 患者的临床和操作特点。
Catheter Cardiovasc Interv. 2020 Nov;96(6):E568-E575. doi: 10.1002/ccd.29134. Epub 2020 Jul 20.
10
Clinical presentation and 3-year outcomes of patients with acute coronary syndromes and non-obstructive coronary arteries on angiography.经造影检查有急性冠脉综合征且冠状动脉无阻塞的患者的临床表现和 3 年结果。
PLoS One. 2020 Jun 16;15(6):e0234735. doi: 10.1371/journal.pone.0234735. eCollection 2020.